about
Antibiotic prophylaxis: different practice patterns within and outside the United StatesEndophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive reviewCoaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF TherapiesEvolving European guidance on the medical management of neovascular age related macular degeneration.Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis)Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathyRisk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.Experimental investigation of needles, syringes and techniques for intravitreal injections.Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbitsRationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edemaEffects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injectionsContrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.Visual perceptions induced by intravitreous injections of therapeutic agents.Evaluation of patients' experiences at different stages of the intravitreal injection procedure - what can be improved?Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection.Serial evaluation of retinal vascular changes in infants treated with intravitreal bevacizumab for aggressive posterior retinopathy of prematurity in zone I.Effects of intravitreal triamcinolone acetonide injection with and without preservative.Chronic cystoid macular oedema treated with intravitreal dobesilate.Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases.Treatment of Stargardt disease with dobesilate.Phacoemulsification and intraocular lens implantation after inadvertent intracapsular injection of intravitreal dexamethasone implantRetinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period.The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy.National survey of the technique of intravitreal triamcinolone injection in the United Kingdom.The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy.Bevacizumab for neovascular ocular diseases.Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure: a comparative clinical study.Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration.Survey of intravitreal injection techniques among retina specialists in Israel.Postoperative endophthalmitis: optimal management and the role and timing of vitrectomy surgery.Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate.Rate of Post-traumatic Endophthalmitis with or without Injection of Balanced Salt SolutionPractice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal survey.Endophthalmitis after intravitreal injections.Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis.A protocol for the retina surgeon's safe initial intravitreal injections.Effect of reflux of drug during intravitreal anti-VEGF therapies on foveal thickness.
P2860
Q26766557-6EA25E42-0DB2-4671-BB28-AB5E8C514231Q28084070-CE24AD2A-B1E3-4A5F-B81B-A4CEB47E297BQ28547260-09F7921D-0334-472D-8247-637E970782AEQ33255038-309F048E-EB9E-442A-8236-662E14237D2DQ33416826-AA58F4B8-8DD4-4B93-A4BF-A19ED4D6AAA0Q33492339-9FDC8511-CB0E-4AE4-9571-6FB5DD002AE7Q33518324-F49579E9-1A59-4D86-A117-8D4BF0BF3365Q33542959-385DB2D4-01A8-432C-A03A-9F4074D433BEQ33727213-2B5EE3F9-D6FB-41F9-A69C-E3C510206C62Q33911625-3E6FA411-7E60-486C-845F-28293A8ECC2BQ34089742-FF6A00B1-6D4B-494F-AD07-C02332BDFBCDQ34390583-65D1CE88-456A-4D71-8ED1-C565A8D72186Q34728113-71F1FD5C-4107-4057-AC32-BAB3CABD5CC3Q35167647-B94A71BC-F437-4995-A198-B41F20B687C8Q35208745-9328B8C4-FC07-4033-8BE9-BBF053223AFAQ35500814-5EC545F7-75FA-4D7A-9B85-65F57D642BA6Q35691908-66EE4AA4-7B9B-4C4B-9FF2-DA7177E0A42DQ35846321-A4DE96AF-C5ED-46E6-9C3F-34543BFD7D6AQ35953960-839CA9F9-AD6B-4111-9954-357D0D5CF2B8Q35977226-0E7EEAF0-920A-404B-A805-6E7A5BCC5ED1Q35977309-1A2BB248-71DB-480E-962C-11FCB06A2560Q35979853-59A335B7-9ADE-49BE-80D3-C47B8CE8864AQ35980294-DD458AAC-CB6D-4B32-907C-52082C2A2C54Q36093275-8A080378-99EA-4D08-BB69-17AB9E8816FDQ36300982-348E553D-A8E7-426B-8CAC-3ECF4F30925AQ36378901-D86C8DB2-17DE-46E3-887F-A56BF5FFA376Q36441711-631C2921-47C1-4D76-824D-415A46E4465AQ36731129-496DF02F-6A13-4872-B92C-E22A08873BDFQ36758847-DB230CE1-276B-4805-834D-09BAB276EF75Q36788545-0497EC5D-CE55-4688-AF3A-046A95883DB1Q36977430-B4C0A7C1-F3A5-40B2-8BD5-4E6B572D7E9FQ37021285-C3B1C53B-4216-4BC0-9314-BAD5D7341336Q37115440-78598DE0-0E96-4E0A-A24E-E3365406C82EQ37314844-F92A1933-905C-4D9D-B408-248DCB46CC41Q37369923-20EFA977-D4D3-4643-A861-544ACC166A71Q37510107-65D6E2F4-F978-4567-8DEE-BC7ABBD92888Q37544827-D6B72A65-0EF8-440C-867A-D94DB644E234Q37763847-C97ECD43-AC00-4110-A762-B935F620CF0AQ37817732-A89B1AAB-E099-41FA-87B4-783945F09863Q37862253-A067EE2C-F34C-49C2-B1BA-9A2A9D758FE5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evolving guidelines for intravitreous injections.
@ast
Evolving guidelines for intravitreous injections.
@en
type
label
Evolving guidelines for intravitreous injections.
@ast
Evolving guidelines for intravitreous injections.
@en
prefLabel
Evolving guidelines for intravitreous injections.
@ast
Evolving guidelines for intravitreous injections.
@en
P2093
P1433
P1476
Evolving guidelines for intravitreous injections.
@en
P2093
Alexander J Brucker
Christopher Ta
Donald J D'Amico
Emmett T Cunningham
Harry W Flynn
Ingrid U Scott
Jeffrey M Liebmann
Lisa R Grillone
Lloyd P Aiello
Michael T Trese
P356
10.1097/00006982-200410001-00002
P433
P577
2004-10-01T00:00:00Z